Company Presentations are selected by an internal review committee considering criteria such as but not limited to: stage of development, intellectual property protection, expected time of next capital raise, whether the technology is licensable, and conference appeal to the life sciences community or other potential partners. Presentations must be given by the company CEO or a designated executive.
Deadline to submit an application is February 6, 2026.
*If your company is selected to present, we ask the presenter to pay $270, which includes one conference registration and a $75 non-refundable presentation fee.